Immuneering Corp (IMRX) stock
Close on Nov 12, 2026Market cap $237.68MP/E –Yield –
Immuneering statistics
63 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 5, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.47
- 2.29
Share statisticsIndustry
- Shares Change (YoY)
- 82.0%
- 10.9%
- Float
- 57M
- 49M
- Shares Held by Insiders
- 11.6%
- 12.1%
- Shares Held by Institutions
- 53.2%
- 56.4%
Short sellingIndustry
- Short Interest
- 15M
- –
- Short Interest Change
- -10.6%
- -0.76%
- Short % of Float
- 25.5%
- 9.04%
- Short % of Shares Outstanding
- 22.5%
- 6.30%
- Days to Cover
- 19.20
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $8.48
- –
- 52-Week Low
- $3.35
- –
- 20-Day Moving Average
- $3.72
- –
- 50-Day Moving Average
- $4.02
- –
- 200-Day Moving Average
- $4.75
- –
- Average True Range (14)
- $0.24
- –
- Price Change (1 Week)
- 8.90%
- 1.51%
- Price Change (1 Month)
- 7.31%
- -2.35%
- Price Change (3 Months)
- -27.5%
- -21.1%
- Price Change (6 Months)
- -28.6%
- -22.6%
- Price Change (YTD)
- -44.2%
- -22.6%
- Price Change (1 Year)
- -45.5%
- -20.7%
- Price Change (3 Years)
- -24.2%
- -27.4%
- Price Change (5 Years)
- -86.8%
- -77.3%
- Average Volume (10 Days)
- 754,765
- –
- Average Volume (20 Days)
- 744,232
- –
- Average Volume (90 Days)
- 722,223
- –
- Relative Volume
- 0.65
- 0.79
- Relative Strength Index (14)
- 46.2
- 44.7
- Volatility (1 Year)
- 81.1%
- 80.4%
- Beta (5 Years)
- 1.18
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -33.5%
- -51.2%
- Return on Assets (ROA)
- -31.4%
- -40.6%
- Return on Invested Capital (ROIC)
- -105.3%
- -32.9%
- Return on Capital Employed (ROCE)
- -43.0%
- -38.0%
Financial positionIndustry
- Current Ratio
- 13.97
- 3.30
- Quick Ratio
- 5.40
- 2.42
EfficiencyIndustry
- Profits Per Employee
- -$1.25M
- -$683.67K
- Employee Count
- 53
- 75
- WACC
- 10.9%
- 10.1%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $58.23M
- $17.46M
- Net Cash Per Share
- $0.90
- $0.72
- Equity (Book Value)
- $168.68M
- $53.27M
- Book Value Per Share
- $2.60
- $1.50
- Tangible Book Value
- $161.69M
- $26.82M
- Working Capital
- $139.92M
- $79.47M
Cash flow (TTM)Industry
- Capital Expenditures
- -$246.37K
- -$944.00K
- FCF Per Share
- -$0.95
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -28.0%
- -20.8%
- FCF Yield
- -26.0%
- -9.58%
Scores and fair valueIndustry
- Altman Z-Score
- 7.29
- 0.30
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | IMRX | S&P 500 | Difference | IMRX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -4.9% | -2.7% | −2.2 pts | ||
| 3 months | -27.6% | -1.7% | −25.9 pts | ||
| Year to date | -44.2% | +11.9% | −56.1 pts | ||
| 1 year | -44.6% | +12.0% | −56.5 pts | ||
| 3 years | -29.2% | +78.2% | −107.4 pts | -10.9% | +21.2% |
| 5 years | -86.8% | +73.2% | −160.1 pts | -33.3% | +11.6% |
| 10 years | +36600.0% | +309.6% | +36290.4 pts | +80.5% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
15M IMRX shares were sold short on Oct 30, 2026, down 10.6% from the previous report, or 25.49% of the shares available to trade. At recent volumes it would take 19.2 days to buy them back. Over the last 20 sessions, 43.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 14,595,733 | -10.6% | 760,062 | 19.2 |
| Oct 15, 2026 | 16,324,569 | +5.4% | 801,860 | 20.4 |
| Sep 30, 2026 | 15,492,438 | -0.4% | 639,765 | 24.2 |
| Sep 15, 2026 | 15,550,745 | +4.8% | 756,551 | 20.6 |
| Aug 31, 2026 | 14,838,835 | +2.9% | 547,452 | 27.1 |
| Aug 14, 2026 | 14,426,945 | -6.3% | 745,013 | 19.4 |
| Jul 31, 2026 | 15,401,519 | +1.3% | 755,903 | 20.4 |
| Jul 15, 2026 | 15,208,579 | +1.2% | 926,955 | 16.4 |
| Jun 30, 2026 | 15,027,581 | +7.1% | 1,974,237 | 7.6 |
| Jun 15, 2026 | 14,027,174 | +10.2% | 2,266,521 | 6.2 |
| May 29, 2026 | 12,724,428 | +28.6% | 2,570,409 | 5.0 |
| May 15, 2026 | 9,893,669 | +4.1% | 663,643 | 14.9 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?